home / stock / cntx / cntx news

CNTX News and Press, Context Therapeutics Inc. From 02/19/25

Stock Information
Company Name: Context Therapeutics Inc.
Stock Symbol: CNTX
Market: NASDAQ
Website: contexttherapeutics.com
Menu
CNTX CNTX Quote CNTX Short CNTX News CNTX Articles CNTX Message Board
Get CNTX Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTX - Context Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the Company will participate in the following investor confer...
CNTX - Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: ...

CNTX - Context Therapeutics names Andy Pasternak as chair

2025-01-13 07:41:45 ET More on Context Therapeutics Seeking Alpha’s Quant Rating on Context Therapeutics Historical earnings data for Context Therapeutics Financial information for Context Therapeutics Read the full article on Seeking Alpha For...

CNTX - Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

Mr. Pasternak brings decades of global pharmaceutical leadership experience Transition further highlights transformation of the Board to lead Context into next phase of growth PHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the &...
Previous 10 Next 10